z-logo
Premium
Epithelium segmentation and automated Gleason grading of prostate cancer via deep learning in label‐free multiphoton microscopic images
Author(s) -
Yang Qinqin,
Xu Zhexin,
Liao Chenxi,
Cai Jianyong,
Huang Ying,
Chen Hong,
Tao Xuan,
Huang Zheng,
Chen Jianxin,
Dong Jiyang,
Zhu Xiaoqin
Publication year - 2020
Publication title -
journal of biophotonics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.877
H-Index - 66
eISSN - 1864-0648
pISSN - 1864-063X
DOI - 10.1002/jbio.201900203
Subject(s) - prostate cancer , segmentation , grading (engineering) , prostate , artificial intelligence , computer science , deep learning , pattern recognition (psychology) , prostatectomy , epithelium , image segmentation , medicine , pathology , cancer , biology , ecology
In the current clinical care practice, Gleason grading system is one of the most powerful prognostic predictors for prostate cancer (PCa). The grading system is based on the architectural pattern of cancerous epithelium in histological images. However, the standard procedure of histological examination often involves complicated tissue fixation and staining, which are time‐consuming and may delay the diagnosis and surgery. In this study, label‐free multiphoton microscopy (MPM) was used to acquire subcellular‐resolution images of unstained prostate tissues. Then, a deep learning architecture (U‐net) was introduced for epithelium segmentation of prostate tissues in MPM images. The obtained segmentation results were then merged with the original MPM images to train a classification network (AlexNet) for automated Gleason grading. The developed method achieved an overall pixel accuracy of 92.3% with a mean F1 score of 0.839 for epithelium segmentation. By merging the segmentation results with the MPM images, the accuracy of Gleason grading was improved from 72.42% to 81.13% in hold‐out test set. Our results suggest that MPM in combination with deep learning holds the potential to be used as a fast and powerful clinical tool for PCa diagnosis.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here